Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
Clinical trial NCT00708773 · COMPLETED
Trial details
- NCT number
- NCT00708773
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2016-08-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.